Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,024 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort.
Miedema MD, Lopez FL, Blaha MJ, Virani SS, Coresh J, Ballantyne CM, Folsom AR. Miedema MD, et al. Among authors: ballantyne cm. JAMA Intern Med. 2015 Jan;175(1):138-40. doi: 10.1001/jamainternmed.2014.6288. JAMA Intern Med. 2015. PMID: 25401375 Free PMC article. No abstract available.
Risk for myopathy with statin therapy in high-risk patients.
Ballantyne CM, Corsini A, Davidson MH, Holdaas H, Jacobson TA, Leitersdorf E, März W, Reckless JP, Stein EA. Ballantyne CM, et al. Arch Intern Med. 2003 Mar 10;163(5):553-64. doi: 10.1001/archinte.163.5.553. Arch Intern Med. 2003. PMID: 12622602 Review.
B vitamin status and inflammatory markers.
Folsom AR, Desvarieux M, Nieto FJ, Boland LL, Ballantyne CM, Chambless LE. Folsom AR, et al. Among authors: ballantyne cm. Atherosclerosis. 2003 Jul;169(1):169-74. doi: 10.1016/s0021-9150(03)00161-8. Atherosclerosis. 2003. PMID: 12860264
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.
Barter PJ, Ballantyne CM, Carmena R, Castro Cabezas M, Chapman MJ, Couture P, de Graaf J, Durrington PN, Faergeman O, Frohlich J, Furberg CD, Gagne C, Haffner SM, Humphries SE, Jungner I, Krauss RM, Kwiterovich P, Marcovina S, Packard CJ, Pearson TA, Reddy KS, Rosenson R, Sarrafzadegan N, Sniderman AD, Stalenhoef AF, Stein E, Talmud PJ, Tonkin AM, Walldius G, Williams KM. Barter PJ, et al. Among authors: ballantyne cm. J Intern Med. 2006 Mar;259(3):247-58. doi: 10.1111/j.1365-2796.2006.01616.x. J Intern Med. 2006. PMID: 16476102 Free article.
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM; ASTEROID Investigators. Nissen SE, et al. Among authors: ballantyne cm. JAMA. 2006 Apr 5;295(13):1556-65. doi: 10.1001/jama.295.13.jpc60002. Epub 2006 Mar 13. JAMA. 2006. PMID: 16533939 Clinical Trial.
How to identify patients with vulnerable plaques.
Virani SS, Ballantyne CM. Virani SS, et al. Among authors: ballantyne cm. Diabetes Obes Metab. 2008 Sep;10(10):824-33. doi: 10.1111/j.1463-1326.2007.00812.x. Epub 2007 Oct 29. Diabetes Obes Metab. 2008. PMID: 17970757 Review.
1,024 results